UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 113

Sortiert nach

Molecular Biology of Lung Cancer: Clinical Implications

Clinics in chest medicine, 2011-12, Vol.32 (4), p.703-740

2011

Volltextzugriff (PDF)

ZEB1 drives epithelial-to-mesenchymal transition in lung cancer

The Journal of clinical investigation, 2016-09, Vol.126 (9), p.3219-3235

2016

Volltextzugriff (PDF)

ASCL1 is a lineage oncogene providing therapeutic targets for high-grade neuroendocrine lung cancers

Proceedings of the National Academy of Sciences - PNAS, 2014-10, Vol.111 (41), p.14788-14793

2014

Volltextzugriff (PDF)

Effect of KRAS Oncogene Substitutions on Protein Behavior: Implications for Signaling and Clinical Outcome

JNCI : Journal of the National Cancer Institute, 2012-02, Vol.104 (3), p.228-239

2012

Volltextzugriff (PDF)

Aldehyde Dehydrogenase Activity Selects for Lung Adenocarcinoma Stem Cells Dependent on Notch Signaling

Cancer research (Chicago, Ill.), 2010-12, Vol.70 (23), p.9937-9948

2010

Volltextzugriff (PDF)

Human lung epithelial cells progressed to malignancy through specific oncogenic manipulations

Molecular cancer research, 2013-06, Vol.11 (6), p.638-650

2013

Volltextzugriff (PDF)

MicroRNA-218 is deleted and downregulated in lung squamous cell carcinoma

PloS one, 2010-09, Vol.5 (9), p.e12560

2010

Volltextzugriff (PDF)

PROTOCADHERIN 7 Acts through SET and PP2A to Potentiate MAPK Signaling by EGFR and KRAS during Lung Tumorigenesis

Cancer research (Chicago, Ill.), 2017-01, Vol.77 (1), p.187-197

2017

Volltextzugriff (PDF)

Knockdown of oncogenic KRAS in non-small cell lung cancers suppresses tumor growth and sensitizes tumor cells to targeted therapy

Molecular cancer therapeutics, 2011-02, Vol.10 (2), p.336-346

2011

Volltextzugriff (PDF)

NeuroD1 regulates survival and migration of neuroendocrine lung carcinomas via signaling molecules TrkB and NCAM

Proceedings of the National Academy of Sciences - PNAS, 2013-04, Vol.110 (16), p.6524-6529

2013

Volltextzugriff (PDF)

Nuclear Receptor Expression and Function in Human Lung Cancer Pathogenesis

PloS one, 2015-08, Vol.10 (8), p.e0134842-e0134842

2015

Volltextzugriff (PDF)

Combined use of subclinical hydroxyurea and CHK1 inhibitor effectively controls melanoma and lung cancer progression, with reduced normal tissue toxicity compared to gemcitabine

Molecular oncology, 2019-07, Vol.13 (7), p.1503-1518

2019

Volltextzugriff (PDF)

Exosomes derived from mesenchymal non‐small cell lung cancer cells promote chemoresistance

International journal of cancer, 2017-08, Vol.141 (3), p.614-620

2017

Volltextzugriff (PDF)

An epithelial-to-mesenchymal transition induced extracellular vesicle prognostic signature in non-small cell lung cancer

Communications biology, 2023-01, Vol.6 (1), p.68-68, Article 68

2023

Volltextzugriff (PDF)

Gene Expression Signature Predicts Recurrence in Lung Adenocarcinoma

Clinical cancer research, 2007-05, Vol.13 (10), p.2946-2954

2007

Volltextzugriff (PDF)

Array-comparative genomic hybridization reveals loss of SOCS6 is associated with poor prognosis in primary lung squamous cell carcinoma

PloS one, 2012-02, Vol.7 (2), p.e30398-e30398

2012

Volltextzugriff (PDF)

Genes and gene ontologies common to airflow obstruction and emphysema in the lungs of patients with COPD

PloS one, 2011-03, Vol.6 (3), p.e17442-e17442

2011

Volltextzugriff (PDF)

Expression profiling identifies genes involved in emphysema severity

Respiratory research, 2009-09, Vol.10 (1), p.81-81, Article 81

2009

Volltextzugriff (PDF)

Loss of miR125a Expression in a Model of K-ras-Dependent Pulmonary Premalignancy

Cancer prevention research (Philadelphia, Pa.), 2014-08, Vol.7 (8), p.845-855

2014

Volltextzugriff (PDF)

ADAM28: A potential oncogene involved in asbestos-related lung adenocarcinomas

Genes chromosomes & cancer, 2010-08, Vol.49 (8), p.688-698

2010

Volltextzugriff (PDF)

Combination Therapy Targeting BCL6 and Phospho-STAT3 Defeats Intratumor Heterogeneity in a Subset of Non-Small Cell Lung Cancers

Cancer research (Chicago, Ill.), 2017-06, Vol.77 (11), p.3070-3081

2017

Volltextzugriff (PDF)

Targeted therapies for lung cancer: clinical experience and novel agents

The cancer journal (Sudbury, Mass.), 2011-11, Vol.17 (6), p.512

2011

Volltextzugriff (PDF)

Systematic siRNA Screen Unmasks NSCLC Growth Dependence by Palmitoyltransferase DHHC5

Molecular cancer research, 2015-04, Vol.13 (4), p.784-794

2015

Volltextzugriff (PDF)

Silencing the Snail-Dependent RNA Splice Regulator ESRP1 Drives Malignant Transformation of Human Pulmonary Epithelial Cells

Cancer research (Chicago, Ill.), 2018-04, Vol.78 (8), p.1986-1999

2018

Volltextzugriff (PDF)

1 – 25 von 113

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(107)
Mit Volltextzugriff
(105)

Publikationsform

Artikel
(108)
Buchkapitel
(5)

Sprache

Englisch
(113)
Japanisch
(25)

Erscheinungsjahr

n.n

Thema

Science & Technology
(71)
Humans
(64)
Life Sciences & Biomedicine
(62)
Female
(31)
Oncology
(25)
Male
(24)
Lung Neoplasms - Genetics
(21)
Lung Cancer
(20)
Middle Aged
(19)
Animals
(17)
Adult
(16)
Biological And Medical Sciences
(16)
Medical Sciences
(16)
Tumors
(15)
Cell Line, Tumor
(14)
Lung Neoplasms - Metabolism
(14)
Aged
(13)
Carcinoma, Non-Small-Cell Lung - Genetics
(13)
Diabetes
(11)
Lung Neoplasms - Pathology
(11)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Molecular Biology of Lung Cancer: Clinical Implications

ZEB1 drives epithelial-to-mesenchymal transition in lung cancer

ASCL1 is a lineage oncogene providing therapeutic targets for high-grade neuroendocrine lung cancers

Systematic Identification of Molecular Subtype-Selective Vulnerabilities in Non-Small-Cell Lung Cancer

Effect of KRAS Oncogene Substitutions on Protein Behavior: Implications for Signaling and Clinical Outcome

Aldehyde Dehydrogenase Activity Selects for Lung Adenocarcinoma Stem Cells Dependent on Notch Signaling

Human lung epithelial cells progressed to malignancy through specific oncogenic manipulations

MicroRNA-218 is deleted and downregulated in lung squamous cell carcinoma

PROTOCADHERIN 7 Acts through SET and PP2A to Potentiate MAPK Signaling by EGFR and KRAS during Lung Tumorigenesis

Knockdown of oncogenic KRAS in non-small cell lung cancers suppresses tumor growth and sensitizes tumor cells to targeted therapy

NeuroD1 regulates survival and migration of neuroendocrine lung carcinomas via signaling molecules TrkB and NCAM

Nuclear Receptor Expression and Function in Human Lung Cancer Pathogenesis

Combined use of subclinical hydroxyurea and CHK1 inhibitor effectively controls melanoma and lung cancer progression, with reduced normal tissue toxicity compared to gemcitabine

Exosomes derived from mesenchymal non‐small cell lung cancer cells promote chemoresistance

An epithelial-to-mesenchymal transition induced extracellular vesicle prognostic signature in non-small cell lung cancer

Gene Expression Signature Predicts Recurrence in Lung Adenocarcinoma

Array-comparative genomic hybridization reveals loss of SOCS6 is associated with poor prognosis in primary lung squamous cell carcinoma

Genes and gene ontologies common to airflow obstruction and emphysema in the lungs of patients with COPD

Expression profiling identifies genes involved in emphysema severity

Loss of miR125a Expression in a Model of K-ras-Dependent Pulmonary Premalignancy

ADAM28: A potential oncogene involved in asbestos-related lung adenocarcinomas

Combination Therapy Targeting BCL6 and Phospho-STAT3 Defeats Intratumor Heterogeneity in a Subset of Non-Small Cell Lung Cancers

Targeted therapies for lung cancer: clinical experience and novel agents

Systematic siRNA Screen Unmasks NSCLC Growth Dependence by Palmitoyltransferase DHHC5

Silencing the Snail-Dependent RNA Splice Regulator ESRP1 Drives Malignant Transformation of Human Pulmonary Epithelial Cells

Suchergebnisse filtern